Table 2.
Sociodemographic characteristics of study participants tested for hepatitis B
| Characteristic | Female | Male | All | |||
|---|---|---|---|---|---|---|
|
|
|
|
||||
| n/N | % | n/N | % | n/N | % | |
| All participants tested | 7201/41 255 | 17 | 2426/41 306 | 6 | 9627/82 561 | 12 |
|
| ||||||
| Age group, years | ||||||
| <5 | 1/501 | 0.2 | 4/485 | 0.8 | 5/986 | 0.5 |
| 5–13 | 17/2092 | 0.8 | 29/2119 | 1.4 | 46/4211 | 1.1 |
| 14–17 | 26/1325 | 2 | 21/1193 | 2 | 47/2518 | 2 |
| 18–24 | 443/6758 | 7 | 115/5131 | 2 | 558/11 889 | 5 |
| 25–34 | 3346/14 961 | 22 | 635/13 446 | 5 | 3981/28 407 | 14 |
| 35–44 | 2644/8734 | 30 | 924/11 039 | 8 | 3568/19 773 | 18 |
| 45–54 | 466/3422 | 14 | 423/4736 | 9 | 889/8158 | 11 |
| 55–64 | 140/1777 | 8 | 166/1898 | 9 | 306/3675 | 8 |
| >65 | 118/1685 | 7 | 109/1259 | 9 | 227/2944 | 8 |
|
| ||||||
| BME density category, %a | ||||||
| <10% | 1713/8849 | 19 | 479/8428 | 6 | 2192/17 277 | 13 |
| 10–29% | 2172/18 589 | 12 | 682/16 810 | 4 | 2854/35 399 | 8 |
| ≥30% | 2847/10 777 | 26 | 1129/13 139 | 9 | 3976/23 916 | 17 |
| >65 | 118/1685 | 7 | 109/1259 | 9 | 227/2944 | 8 |
|
| ||||||
| GP registration status | ||||||
| Currently registered | 6384/32 558 | 20 | 2136/33 662 | 6 | 8520/66 220 | 13 |
| Deducted | 817/8697 | 9 | 290/7644 | 4 | 1107/16 341 | 7 |
|
| ||||||
| Requestor of first chronological test | ||||||
| Antenatal | 3857/7201 | 54 | – | – | – | – |
| GP/primary care | 2452/7201 | 34 | 1626/2426 | 67 | 4078/9627 | 42 |
| Other | 892/7201 | 12 | 800/2426 | 33 | 1692/9627 | 18 |
a
BME density category: percentage of black and ethnic minority (BME) inhabitants in the Bristol administrative ward of participants’ GP practice.